Back
Patria Latin American Opportunity Acquisition Vs. Avidity Biosciences Industry Stock Comparison
Sell
33
PLAO
Patria Latin American Opportunity Acquisition
Last Price:
11.63
Seasonality Move:
1.89%
Sell
28
RNA
Avidity Biosciences
Last Price:
41.33
Seasonality Move:
39.98%
Sell
33
Patria Latin American Opportunity Acquisition (PLAO)
is a Sell
Is Patria Latin American Opportunity Acquisition a Buy, Sell or Hold?
- The current Patria Latin American Opportunity Acquisition [PLAO] share price is $11.63. The Score for PLAO is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
- PLAO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
28
Avidity Biosciences (RNA)
is a Sell
Is Avidity Biosciences a Buy, Sell or Hold?
- The current Avidity Biosciences [RNA] share price is $42.18. The Score for RNA is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
- RNA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PLAO Stock Price Chart
What is Patria Latin American Opportunity Acquisition's stock price today?
-
The Patria Latin American Opportunity Acquisition share price today is $11.63
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PLAO is experiencing slight buying pressure.
RNA Stock Price Chart
What is Avidity Biosciences's stock price today?
-
The Avidity Biosciences share price today is $42.18
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RNA is experiencing selling pressure, which indicates risk of future bearish movement.
PLAO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.01 | Buy |
Relative Strength Index (14 RSI): | 65.65 | Buy |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (11.61 - 11.63) | Buy |
Bollinger Bands (100): | (11.5 - 11.62) | Buy |
RNA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.53 | Buy |
Relative Strength Index (14 RSI): | 42.17 | Sell |
Chaikin Money Flow: | -1839481 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (43.78 - 48.76) | Sell |
Bollinger Bands (100): | (41.56 - 46.96) | Sell |
PLAO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 11.63 | Buy |
20-day SMA: | 11.62 | Buy |
50-day SMA: | 11.61 | Buy |
200-day SMA: | 11.44 | Buy |
8-day EMA: | 11.63 | Buy |
20-day EMA: | 11.62 | Buy |
50-day EMA: | 11.6 | Buy |
200-day EMA: | 11.43 | Buy |
RNA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 47.51 | Sell |
20-day SMA: | 45.87 | Sell |
50-day SMA: | 45.1 | Sell |
200-day SMA: | 34.2 | Buy |
8-day EMA: | 46.84 | Sell |
20-day EMA: | 46.32 | Sell |
50-day EMA: | 45.24 | Sell |
200-day EMA: | 35.58 | Buy |
Patria Latin American Opportunity Acquisition Earnings Growth & PLAO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Avidity Biosciences Earnings Growth & RNA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.02 per share, and a decrease next year of $0.24 per share.
Patria Latin American Opportunity Acquisition Technical Analysis
Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Avidity Biosciences Technical Analysis
Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |